Welcome to our dedicated page for Ionq SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The IonQ, Inc. (NYSE: IONQ) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI-powered summaries to help interpret complex documents. As a quantum platform company active in computing, networking, sensing, and security, IonQ uses its SEC filings to report on capital markets activity, acquisitions, governance changes, and executive compensation arrangements.
Investors can review Form 8-K filings where IonQ reports material events such as underwriting agreements for common stock, pre-funded warrants, and Series B warrants, as well as prospectus supplements covering resales of common stock by selling stockholders. Other 8-Ks describe unregistered sales of equity securities, registration rights agreements with institutions like Oxford Science Enterprises and Fortis Advisors, and the completion of acquisitions such as Oxford Ionics Limited and Vector Atomic, Inc.
Filings also detail board and executive changes. Recent 8-Ks and amendments outline the appointment of new directors, the transition of existing directors into advisory roles, and separation agreements for senior executives under IonQ’s Amended and Restated Executive Severance Plan. These documents specify cash severance, COBRA benefits, and equity vesting terms, providing insight into leadership transitions and compensation structures.
Through its registration statements and related supplements, IonQ discloses information about listed securities, including common stock and warrants trading on the New York Stock Exchange under the symbols IONQ and IONQ WS. AI-generated highlights on this page help users quickly identify key terms such as warrant exercise prices, expiration dates, and adjustment mechanisms, as well as the implications of registration rights and resale arrangements.
By using this filings page, readers can follow IonQ’s equity offerings, acquisition-related share issuances, insider and governance updates, and other regulatory disclosures, while AI summaries assist in understanding how each filing may relate to ownership, dilution, and the company’s strategic transactions.
IONQ reported a planned insider sale of company stock under Rule 144. The person filing intends to sell 24,030 shares of IONQ common stock through E-TRADE Financial Corporation on the NYSE, with an approximate sale date of 12/11/2025. The shares have an aggregate market value of
The 24,030 shares to be sold were acquired on
IonQ, Inc. (IONQ) received a Form 144 notice for a planned sale of 230,090 shares of its common stock through E-TRADE Financial Corporation on the NYSE, with an approximate sale date of 12/11/2025. The aggregate market value of the planned sale is stated as 12,123,442, and the number of common shares outstanding is 354,279,591.
The shares to be sold were acquired on 12/10/2025 via the vesting of restricted stock units as equity compensation from the issuer. The seller has also sold common stock of IonQ during the past three months, including 133,615 shares on 12/09/2025 for gross proceeds of 7,181,124.81 and several earlier transactions in November and September 2025.
IonQ insider files to sell recently vested shares. A Form 144 notice discloses that an IonQ, Inc. affiliate plans to sell 17,690 shares of common stock through E-TRADE Financial Corporation on the NYSE, with an approximate sale date of 12/11/2025 and an aggregate market value of 932,086. These shares were acquired on 12/10/2025 through the vesting of restricted stock units as equity compensation from the issuer.
The filing also notes that, during the past three months, Niccolo de Masi sold 16,120 shares of IonQ common stock on 09/11/2025 for gross proceeds of 715,753.79. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about IonQ’s current or prospective operations.
IonQ filed a notice of planned stock sales under Rule 144. The filing covers the proposed sale of 15,420 shares of common stock through E-TRADE Financial Corporation on the NYSE, with an aggregate market value of 812,480. The shares are part of a much larger base of 354,279,591 shares outstanding. These shares were acquired on 12/10/2025 through the vesting of restricted stock units as equity compensation from the issuer, with the sale expected around 12/11/2025.
IonQ had an affiliate file a notice of proposed sale of restricted stock under Rule 144. The filing covers 133,615 shares of common stock to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $7,181,124.81. These shares were acquired on 12/09/2025 by exercising options under a registered plan, paid for in cash on the same date. The notice states that 354,279,591 shares of common stock were outstanding.
Over the prior three months, the same or related holders sold additional IonQ common shares in several transactions, including 100,000 shares on 11/20/2025 and 19,976 shares on 09/11/2025, for total disclosed gross proceeds in the multi-million dollar range. By signing the notice, the seller represents they do not know of any material adverse information about IonQ’s operations that has not been publicly disclosed.
IonQ, Inc. disclosed the equity holdings of its Chief Business Officer in a regulatory ownership report. The executive beneficially owns 236,043 shares of common stock, held directly. This total reflects 800 shares of common stock and two restricted stock unit (RSU) awards that vest over time.
One RSU award covers 64,157 RSUs, vesting over two years, with 42,771 shares vesting on December 10, 2025 and 21,386 shares vesting on December 10, 2027, subject to continued service. A second RSU award covers 171,086 RSUs, vesting over four years, with 25% vesting on December 10, 2026 and the remainder vesting quarterly on March 10, June 10, September 10, and December 10 thereafter, also conditioned on ongoing service.
IonQ, Inc. filed an amended current report to add details of the separation agreement with its former Chief Financial Officer, Thomas Kramer. The amendment explains that, under the company’s executive severance plan and his performance-based equity award, Kramer will receive a lump-sum cash severance equal to nine months of base salary, his full 2025 target bonus and an additional pro-rated 2025 bonus for the period he worked, payable after his release of claims becomes effective.
IonQ will also cover his health insurance premiums under COBRA for up to nine months if he elects continuation coverage. All of his unvested restricted stock units and certain unvested stock options will fully vest, while remaining unvested options will be forfeited, and his performance stock units will vest at target, adjusted for the portion of the performance period he served. The amendment does not change other disclosures in the original report.
A shareholder of IONQ filed a Form 144 notice covering a planned sale of 25,000 common shares through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $1,216,250. The filing notes that there were 354,279,591 common shares outstanding as of the time referenced. The shares to be sold stem from 25,000 restricted stock units acquired on 09/10/2024 from the issuer.
The seller, identified in the past‑sales section as Rima Alameddine, reports additional common share sales in the prior three months under a Rule 10b5‑1 trading plan, including 25,000 shares on 11/28/2025 for $1,241,500.00, 100,000 shares on 11/20/2025 for $4,689,060.00, and 19,976 shares on 09/11/2025 for $886,966.36. The new 25,000‑share sale is expected around 12/04/2025.
IonQ Inc. has a shareholder filing a notice under Rule 144 to sell 1,400,000 shares of its common stock through Merrill Lynch on the NYSE, with an aggregate market value of $65,098,758.20 as of the notice. The filing notes that 354,279,591 shares of common stock were outstanding. The 1,400,000 shares to be sold were acquired on 02/09/2021 via a stock option transaction from Thomas Kramer, with payment also made on that date through the stock option.
IonQ, Inc. insider Rima Alameddine has filed a Form 144 notice to sell 25,000 shares of IonQ common stock through Morgan Stanley Smith Barney LLC on the NYSE around 11/28/2025, with an aggregate market value of
The 25,000 shares to be sold were acquired on 12/10/2023 as restricted stock units from the issuer. Over the prior three months, the seller completed additional common stock sales, including 100,000 shares on
FAQ
What is the current stock price of Ionq (IONQ)?
What is the market cap of Ionq (IONQ)?
